S&P 500   3,852.36
DOW   32,920.46
QQQ   294.62
7 Safe Investments with Relatively High Returns for 2023
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Lucid Group's Buyout Rumors Continue
Dividend King Sysco: Buying On The Dip 
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Will Caterpillar Dig Its Way To Another Buying Opportunity? 
Wall Street climbs to add more to its strong January
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
Carvana Is Up 39.28% In One Week: Is It The Newest Meme Stock?
S&P 500   3,852.36
DOW   32,920.46
QQQ   294.62
7 Safe Investments with Relatively High Returns for 2023
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Lucid Group's Buyout Rumors Continue
Dividend King Sysco: Buying On The Dip 
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Will Caterpillar Dig Its Way To Another Buying Opportunity? 
Wall Street climbs to add more to its strong January
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
Carvana Is Up 39.28% In One Week: Is It The Newest Meme Stock?
S&P 500   3,852.36
DOW   32,920.46
QQQ   294.62
7 Safe Investments with Relatively High Returns for 2023
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Lucid Group's Buyout Rumors Continue
Dividend King Sysco: Buying On The Dip 
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Will Caterpillar Dig Its Way To Another Buying Opportunity? 
Wall Street climbs to add more to its strong January
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
Carvana Is Up 39.28% In One Week: Is It The Newest Meme Stock?
S&P 500   3,852.36
DOW   32,920.46
QQQ   294.62
7 Safe Investments with Relatively High Returns for 2023
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Lucid Group's Buyout Rumors Continue
Dividend King Sysco: Buying On The Dip 
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Will Caterpillar Dig Its Way To Another Buying Opportunity? 
Wall Street climbs to add more to its strong January
Huge Upside Potential With "Staggering" Solar Demand (Ad)
Verizon, Charter Trend Higher In Past Month: Are They Buys Now?
Carvana Is Up 39.28% In One Week: Is It The Newest Meme Stock?
CVE:LTY

Liberty Biopharma - LTY Stock Forecast, Price & News

C$2.00
+2.00 (+∞)
(As of 10/10/2018)
Add
Compare
Today's Range
C$2.00
C$2.00
50-Day Range
C$2.00
C$2.00
52-Week Range
C$0.06
C$2.74
Volume
700 shs
Average Volume
23,286 shs
Market Capitalization
C$21.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

LTY stock logo

About Liberty Biopharma (CVE:LTY) Stock

Liberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.

Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

LTY Stock News Headlines

Move Over Lithium – 220 Pounds of Graphite In Every EV Battery
Investors constantly hear that lithium is the key to powering our transition to electric vehicles and clean energy. Truth is, switching from gas-powered isn't possible without massive amounts of graphite. But America hasn't produced any graphite since the 1950s. Now, a little-known exploration company has defined America's largest high-quality graphite deposit near Nome, Alaska.
Liberty Defense to Beta Test HEXWAVE System with Top US Airline
Liberty Advisor Group Named One of 2022 Best Places to Work in Chicago
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery
Investors constantly hear that lithium is the key to powering our transition to electric vehicles and clean energy. Truth is, switching from gas-powered isn't possible without massive amounts of graphite. But America hasn't produced any graphite since the 1950s. Now, a little-known exploration company has defined America's largest high-quality graphite deposit near Nome, Alaska.
Liberty Two Degrees (L2DJ)
Liberty Energy Is Working To Complete Turnaround Strategy
Liberty Financial Group Pty Ltd (LFG)
Liberty Shoes Ltd (LIBS)
Liberty Diversified names new president, CEO
DMG Bancshares, Inc. to Acquire Liberty Bancorp
See More Headlines
Receive LTY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
C$0.00 per share
Book Value
C$0.79 per share

Miscellaneous

Free Float
N/A
Market Cap
C$21.54 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Norman Tsui (Age 45)
    Pres, CEO & Director
  • Mr. Shui Yan Tam (Age 44)
    Chief Financial Officer
  • Dr. Michael T. McNamara
    Medical Advisor & Director
  • Dr. Richard Huang Ph.D. (Age 42)
    Chief Technology Officer
  • Dr. Richard Cook M.D.
    Msc., FRCSC, Chief Medical Officer













LTY Stock - Frequently Asked Questions

How have LTY shares performed in 2023?

Liberty Biopharma's stock was trading at C$2.00 at the beginning of 2023. Since then, LTY stock has increased by 0.0% and is now trading at C$2.00.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Liberty Biopharma own?
What is Liberty Biopharma's stock symbol?

Liberty Biopharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LTY."

How do I buy shares of Liberty Biopharma?

Shares of LTY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Liberty Biopharma's stock price today?

One share of LTY stock can currently be purchased for approximately C$2.00.

How much money does Liberty Biopharma make?

Liberty Biopharma (CVE:LTY) has a market capitalization of C$21.54 million.

How can I contact Liberty Biopharma?

Liberty Biopharma's mailing address is 2270-8788 McKim Way, RICHMOND, BC V6X 4E2, Canada. The official website for the company is www.libertybiopharma.com. The biotechnology company can be reached via phone at +1-604-3777575.

This page (CVE:LTY) was last updated on 2/1/2023 by MarketBeat.com Staff